| Code | 5229C | ||||||||||
| MA number | 44/0272/17-S | ||||||||||
| Product Form: | plo ijf 1x40 mg (liek.inj.skl.jantárová) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(3) hybrid application |
| MA issued: | 29.09.2017 |
| SPC: |
SPC_Mitomycin Accord 40 mg_01/2019.doc.docx
|
| PIL: |
PIL_Mitomycin Accord 40 mg prášok na injekčný_infúzny roztok_12.2022.pdf
|
| Safety feature | Yes |
| Data update: | 06.03.2023 |
